Scott Collins, PhD

Board of Directors President

I am passionate about eliminating the world’s problems through new and existing technologies alike. Most recently, I have applied this to human health. I can visualize the various pathways from technology creation to sustainable market, and guide companies more expeditiously towards success. I hate seeing companies flounder and technologies die on the vine. I like bringing clarity to ambiguity.

I am an experienced startup executive with cross-industry expertise spanning corporate formation through sale. I bring a multi-perspective approach to success, drawing from knowledge in entrepreneurship, biotechnology, tissue and organ engineering, biofabrication, communications, and software development. I am a creative out-of-the-box thinker who can combine existing technologies and novel innovations to sustainably solve problems and improve processes.

Timothy Sullivan

Board of Directors Member

A technology innovator and entrepreneur, I have created constructive disruptive technologies, products and services and grown more than a half dozen companies in several industry sectors over four decades. I have been granted 30+ US and international patents in the field of therapeutic drug and biologic delivery, my passion for over a decade has been the development and commercialization of advanced pharmaceutical drug/device combination products that protect the quality of human life.

Specialties: strategic foresight – see the big picture and higher order implications, innovate and commercialize breakthrough technologies, products and services that solve real-world problems, strategy development and execution, building and motivating high performance teams to make it happen.

Hilary Graham, PhD, MA

Board of Directors Member

I’m storyteller and commercial strategist with a growth mindset specializing in the molecular diagnostics and life sciences markets. People are my passion… both customer satisfaction and team development.   

I lead Marketing for the Molecular Diagnostics Division of Bio-Techne, which includes the Asuragen, Exosome Diagnostics, Armored Molecular Controls and Companion Diagnostics franchises. I’m responsible for portfolio strategy, product management, and content marketing.  Previously to Bio-Techne, I led marketing and application science for the xMAP multiplexing franchise at Luminex and was leading the launch of the INTELLIFLEX system when I departed. Before joining Luminex I worked in a variety of commercial and technical communications roles at Syneos Health and UT MD Anderson Cancer Center.

Cindy R. WalkerPeach, PhD

Board of Directors Member

Dr. WalkerPeach currently leads the development of the Nexxus Project at the University of Texas at Austin and serves on the national faculty for the National Institutes of Health (NIH) and National Science Foundation (NSF) Innovation Corps (I-Corps) Programs.  Prior to returning to UT-Austin, she was the Chief Product Development Officer at the Cancer Prevention & Research Institute of Texas (CPRIT) where she was responsible for critical evaluation and investment in companies with promising novel oncology products (drugs, diagnostics, medical devices).  Prior to CPRIT, Dr. WalkerPeach served as Program Officer for NSF I-Corps, which prepared academic scientists and engineers to assess the commercial opportunity of their technologies.  Preceding government service, Dr. WalkerPeach had more than 20 years of experience in the biotechnology sector as a member of several life science management teams, where she led product development and commercial operations.  Dr. WalkerPeach completed a BS in Chemistry, holds a PhD in Molecular Biology and completed an industry fellowship.

Ryan Hawkins

Board of Directors Member

Accomplished biopharmaceutical business leader with over twenty-five years experience moving novel therapies, solutions and technologies from development to commercialization in the life science industry. Proven track record of managing a full P&L, deploying capital and leading complex projects, building teams, and leveraging technology to manage the product lifecycle in the biopharmaceutical industry. Results focused leader passionate about creating positive change and building organizational value.

Enabled organizational growth and operationally scaled multiple organizations in positions of influence to inflection points or divestiture. Successfully led and managed P&Ls in both private and publicly held entities. Believer in people, leading with positive energy, and working from position of confidence in decision making.